Prognostic and Predictive Implications of PTEN in Breast Cancer: Unfulfilled Promises but Intriguing Perspectives
Luisa Carbognin(Agostino Gemelli University Polyclinic), Maria Vittoria Dieci(Istituto Oncologico Veneto), Federica Miglietta(University of Padua), Ida Paris(Agostino Gemelli University Polyclinic)
Cited by 115
Related Papers
Evolution of HER2-low expression from primary to recurrent breast cancer
|npj Breast Cancer|2021|226
HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade
|JNCI Journal of the National Cancer Institute|2019|168
The immune system and hormone-receptor positive breast cancer: Is it really a dead end?
|Cancer Treatment Reviews|2016|128
Neoadjuvant Chemotherapy and Immunotherapy in Luminal B-like Breast Cancer: Results of the Phase II GIADA Trial
|Clinical Cancer Research|2021|115